This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 2 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Other. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: Masako Matsumoto: Innovator in Physiologically Active Peptides
Introduction
Masako Matsumoto is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of liquid preparations for physiologically active peptides. His work focuses on enhancing the bioavailability of these peptides, which are crucial for various medical applications.
Latest Patents
Matsumoto holds a patent for a "Liquid preparation of physiologically active peptide." This innovative preparation achieves high bioavailability of physiologically active peptides or proteins, including ghrelins, when administered as drugs. The patent also outlines a method for improving the bioavailability of these peptides when subcutaneously injected in aqueous solutions. The liquid preparation consists of a physiologically active peptide or protein, an acid solution, an alcohol, and a polar organic liquid.
Career Highlights
Throughout his career, Masako Matsumoto has worked with prominent companies, including Daiichi Sankyo Company, Limited. His expertise in biochemistry and innovative approaches have positioned him as a key figure in the development of effective drug delivery systems.
Collaborations
Matsumoto has collaborated with notable colleagues, including Takeshi Hanada and Naomi Wakabayashi. Their combined efforts have contributed to advancements in the field of physiologically active peptides.
Conclusion
Masako Matsumoto's work in the development of liquid preparations for physiologically active peptides showcases his innovative spirit and dedication to improving drug delivery methods. His contributions are significant in the realm of biochemistry and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile